Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7525917 | 0.91 | TACR1 (0.77) | TACR1TACR3 | |
| SCHEMBL7532240 | 0.91 | TACR1 (0.77) | TACR1TACR3 | |
| SCHEMBL7530989 | 0.91 | TACR1 (0.78) | TACR1TACR3 | |
| SCHEMBL7525927 | 0.91 | TACR1 (0.77) | TACR1TACR3 | |
| SCHEMBL7523633 | 0.91 | TACR1 (0.68) | TACR1TACR3 | |
| SCHEMBL7062087 | 0.88 | TACR1 (0.76) | TACR1TACR3 | |
| SCHEMBL27587064 | 0.86 | TACR1 (0.66) | TACR1TACR3 | |
| SCHEMBL7846815 | 0.85 | TACR1 (0.68) | TACR1TACR3 | |
| SCHEMBL7067703 | 0.85 | TACR1 (0.68) | TACR1TACR3 | |
| SCHEMBL7528982 | 0.84 | TACR1 (0.79) | TACR1TACR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1244653-A1 | NON PEPTIDE TACHYKININ RECEPTOR ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 2002-10-02 | — | — | EP | claimed |
| WO-2001046176-A2 | NON PEPTIDE TACHYKININ RECEPTOR ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 2001-06-28 | — | — | WO | claimed |
| CN-1413206-A | Non peptide tachykinin receptor antagonists | WARNER LAMBERT CO (US) | 2003-04-23 | — | — | CN | disclosed |
| EP-1244653-A1 | NON PEPTIDE TACHYKININ RECEPTOR ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 2002-10-02 | — | — | EP | disclosed |
| WO-2001046176-A2 | NON PEPTIDE TACHYKININ RECEPTOR ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 2001-06-28 | — | — | WO | disclosed |